Healthspan Education
Book materials, public resources, seminars, and member updates.
Paired agent: Educator Agent
Research & Insights
Research coordination, not medical claims.
The Alliance organizes education and participation around longevity research while keeping clear boundaries between public education, physician-led care, research review, and technology infrastructure. Below: how we organize research, the one competition where an Alliance council member is directly competing, and where ATLAS fits as infrastructure.
Our AI agents operate only in that last layer — they coordinate and organize; they do not diagnose, treat, or make clinical decisions.
Research Themes
How the Alliance organizes research.
Participant Journey
Apply, consent, receive updates, attend, engage, and choose next steps.
Paired agent: Journey Agent
Verified Delivery
Organized records that show what happened, when, and under what permissions.
Paired agent: Ledger Agent
Partner Review
Practitioner, foundation, partner, and institutional lanes kept distinct.
Paired agent: Review Agent
The ATLAS Agents
Coordination, not decision-making.
The Alliance uses a set of AI agents to keep research organized, records clean, and the field well-monitored. Each agent supports one lane of the work — and each has a hard limit: agents assist people, they never replace the physician, the reviewer, or the participant's own choice.
Educator Agent
Keeps book materials, seminar resources, and member updates current and consistent. Supports Healthspan Education.
Journey Agent
Guides participants through apply, consent, updates, and next-step options, and flags anything needing a human. Supports the Participant Journey.
Ledger Agent
Organizes consent-based records so it's always clear what happened, when, and under what permission. Supports Verified Delivery, writing into ATLAS QuantumVault.
Review Agent
Keeps practitioner, foundation, partner, and institutional lanes distinct and routes items to the right human reviewer. Supports Partner Review.
Field Agent
Continuously scans public research and the XPRIZE Healthspan field, summarizing developments for the Alliance — keeping the Broader Field section current.
Every agent runs inside ATLAS, under the same consent and audit rules as the rest of the platform. No agent has authority over a clinical decision. That authority stays with licensed physicians.
The Lionheart Connection
An Alliance council member is competing in the XPRIZE Healthspan.
XPRIZE Healthspan is a seven-year, $101 million global competition launched in 2023, challenging teams to develop therapies that restore muscle, cognitive, and immune function by at least ten years in adults aged 50–80. More than 600 teams from 58 countries entered. In May 2025, the field was narrowed to 100 semifinalists, of whom the Top 40 each received a $250,000 Milestone 1 award to begin early-stage clinical trials.
Among the leadership of the Phenomenal Longevity Alliance is Dr. Howard Leonhardt, whose company Lionheart is part of this field — bringing decades of regenerative-medicine and bioelectric research to the healthspan question.
The milestone ahead. In July 2026, XPRIZE will narrow the field to 10 finalists for a second $10 million milestone prize, with finalist trials running 2026–2029 and a grand prize of up to $81 million awarded in 2030. We will update this page as the field narrows. Standings here reflect the May 2025 Top 40 announcement.
The Broader Field
A diverse and serious field.
Kept current by the Field Agent.
The semifinalist field spans biologics, devices, drugs, lifestyle interventions, and personalized monitoring — from university labs and hospital institutes to clinical-stage biotech companies on multiple continents. Approaches range from stem-cell and exosome therapies to mitochondrial-energy compounds, senolytics targeting aging cells, immune-system regeneration, and circadian and dietary protocols.
We follow this field because it represents the credible, evidence-driven end of longevity science — the same standard the Alliance holds itself to. We do not claim affiliation with these teams, and nothing here implies endorsement in either direction.
Where ATLAS Fits
Infrastructure, not therapy.
ATLAS is not a competitor in this field and makes no therapeutic claim. Where ATLAS contributes is the layer beneath any longevity program: participant onboarding, consent-based records, device identity, session telemetry, timestamps, adherence logs, and audit-ready evidence — protected by QuantumVault.
The reason this matters: across the whole field, teams face the same operational hurdle — proving, cleanly and defensibly, what was delivered, to whom, when, and under what permissions. That is the problem ATLAS exists to solve. It changes no clinical result; it makes the record around delivery trustworthy.
The ATLAS Agents run inside this infrastructure. They automate the coordination work — onboarding, record organization, field monitoring — but they change no clinical result and hold no clinical authority. Like ATLAS itself, they make the record around delivery trustworthy; they do not practice medicine.
ATLAS QuantumVault
- Consent-based participant onboarding
- Device identity and session telemetry
- Timestamps and adherence logs
- Audit-ready evidence organization
- Sensitive-record protection
Sources